BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,236,000 | +196.8% | 13,750,000 | +205.6% | 0.01% | +200.0% |
| Q2 2018 | $4,797,000 | +3.8% | 4,500,000 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $4,623,000 | -40.7% | 4,500,000 | -33.3% | 0.00% | -70.0% |
| Q1 2016 | $7,802,000 | -81.3% | 6,743,000 | -79.2% | 0.01% | -78.3% |
| Q4 2015 | $41,694,000 | +8.2% | 32,393,000 | +9.8% | 0.05% | +24.3% |
| Q3 2015 | $38,546,000 | -20.0% | 29,500,000 | -4.8% | 0.04% | -11.9% |
| Q2 2015 | $48,165,000 | +554.1% | 31,000,000 | +520.0% | 0.04% | +500.0% |
| Q1 2015 | $7,364,000 | +24.6% | 5,000,000 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $5,911,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|